| Literature DB >> 20584331 |
Omar J Jabado1, Sean Conlan, Phenix-Lan Quan, Jeffrey Hui, Gustavo Palacios, Mady Hornig, Thomas Briese, W Ian Lipkin.
Abstract
BACKGROUND: The analysis of oligonucleotide microarray data in pathogen surveillance and discovery is a challenging task. Target template concentration, nucleic acid integrity, and host nucleic acid composition can each have a profound effect on signal distribution. Exploratory analysis of fluorescent signal distribution in clinical samples has revealed deviations from normality, suggesting that distribution-free approaches should be applied.Entities:
Mesh:
Year: 2010 PMID: 20584331 PMCID: PMC2909221 DOI: 10.1186/1471-2105-11-354
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.307
Viral isolates
| Genome Type | Approximate genome size (kb) | Family | Virus/strain | Abbreviation |
|---|---|---|---|---|
| + sense ssRNA | 11 | Flaviviridae | West Nile virus New York 1999 | WNV |
| + sense ssRNA | 30 | Coronaviridae | SARS Human Coronavirus Tor2 | HCoV-SARS |
| + sense ssRNA | 7.4 | Picornaviridae | Human Echovirus 18 Metcalf | EV18 |
| - sense ssRNA | 3.4 and 7.3 | Arenaviridae | Lassa virus strain Josiah | LASV |
| - sense ssRNA | 19 | Filoviridae | Zaire ebolavirus | ZEBOV |
| - sense ssRNA | 11 | Rhabdoviridae | Vesicular stomatitis virus Indiana | VSV |
| - sense ssRNA | 0.89 to 2.3 | Orthomyxoviridae | Influenza A H1N1 Texas 1991 | FLUA H1N1 |
| dsDNA | 36 | Adenoviridae | Human adenovirus 4 | HAdV-4 |
| dsDNA | 156 | Herpesviridae | Human herpesvirus 1 | HSV-1 |
Figure 1The effect of increasing human nucleic acid on the hybridization signal. Three quantities, 200, 10 and 0 ng of human lung RNA (panels a, b, c), were hybridized to a pathogen microarray comprised of ~38,000 probes. The fluorescent signal from the pathogen-specific probes was log-transformed and used to generate histograms. An expected normal (Gaussian) distribution is depicted by the line in the above figure. Tests for normality indicated significant deviation, with the following Kolmogorov-Smirnov Z values: (a) 41.5, (b) 14.6, (c) 12.1 (all p < 0.01).
Correlation between replicate and reverse complemented probe pairs
| Pearson Correlation (R) | No West Nile Virus | ||||||
|---|---|---|---|---|---|---|---|
| Replicates | Reverse Complements | Replicates | Reverse Complements | Replicates | Reverse Complements | ||
| Overall | West Nile Virus probes | 0.92 | 0.85 | 0.88 | 0.72 | 0.83 | 0.27 |
| non-target probes | 0.72 | 0.27 | 0.75 | 0.31 | 0.79 | 0.35 | |
| Tenth | West Nile Virus probes | 0.90 | 0.83 | 0.84 | 0.68 | 0.77 | ·-0.01 † |
| non-target probes | 0.86 | 0.36 | 0.85 | 0.40 | 0.79 | 0.19 | |
| n = 11 | n = 12 | n = 3 | |||||
p < .05 for all except †
False positive rates for methods of pathogen identification
| False Positive Rate | ||||||
|---|---|---|---|---|---|---|
| Target | Mann-Whitney | Spearman Correlation | Binomial test | |||
| GC Corrected | GC Corrected | GC Corrected | ||||
| WNV | 0% | 0% | 0% | 0% | 0% | 0% |
| HCoV-SARS | 7% | 0% | 100% | 0% | 0% | 0% |
| EV18 | 63% | 15% | 100% | 12% | 14% | 0% |
| LASV | 11% | 0% | 100% | 0% | 0% | 0% |
| ZEBOV | 0% | 0% | 0% | 0% | 0% | 0% |
| VSV | 0% | 0% | 0% | 0% | 0% | 0% |
| HAdV-4 | 100% | 30% | 100% | 5% | 18% | 0% |
| FLUA H1N1 | 20% | 1% | 100% | 0% | 0% | 0% |
| HSV-1 | 8% | 0% | 0% | 1% | 2% | 0% |
| Negative Control (200 ng HuDNA) | 100% | 0% | 1% | 0% | 1% | 0% † |
| Negative Control (200 ng HuDNA) | 100% | 0% | 100% | 1% | 1% | 0% |
| Negative Control (200 ng HuDNA) | 100% | 0% | 100% | 1% | 1% | 0% |
| Negative Control (200 ng HuDNA) | 100% | 0% | 100% | 0% | 1% | 0% |
| Negative Control (10 ng HuDNA) | 100% | 0% | 88% | 0% | 2% | 0% |
| Negative Control | 100% | 0% | 100% | 0% | 0% | 0% † |
| Negative Control | 0% | 0% | 0% | 0% | 0% | 0% |
| Negative Control | 4% | 0% | 2% | 0% | 0% | 0% |
† Hybridization performed on different days
Positive predictive value for methods of pathogen identification
| WNV | 100% | 100% | 100% | 0% | 0% | 0% | 100% | 100% | 100% |
| HCoV-SARS | 50% | 33% | 50% | 0% | 0% | 0% | 50% | 100% | 100% |
| EV18 | 92% | 95% | 91% | 92% | 100% | 96% | 95% | 100% | 96% |
| LASV | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 100%† |
| ZEBOV | 100% | 100% | 100% | 0% | 0% | 0% | 100% | 100% | 100% |
| VSV | 100% | 100% | 100% | 0% | 0% | 0% | 100% | 100% | 100% |
| HAdV-4 | 48% | 74% | 32% | 0% | 100% | 0% | 85% | 89% | 73% |
| FLUA H1N1 | 99% | 96% | 95% | 100% | 100% | 100% | 100% | 100% | 97% |
| HSV-1 | 83% | 100% | 71% | 0% | 0% | 0% | 63% | 100% | 54% |
Top 250 predictions; q value threshold = 0.1
† LASV is targeted by four probes
Performance of Mann-Whitney U and Binomial tests with ViroChip pathogen microarray platform
| Respiratory | Rhinovirus | Influenza A | Papillomavirus | Hepatitis B | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rank of First Correct Prediction | Mann Whitney U | Binomial Test | Mann Whitney U | Binomial Test | Mann Whitney U | Binomial Test | Mann Whitney U | Binomial Test | Mann Whitney U | Binomial Test | Mann Whitney U | Binomial Test |
| First | 40% | 50% | 77% | 86% | 29% | 71% | 20% | 80% | 0% | 0% | 47% | 75% |
| Top 5 | 90% | 100% | 100% | 95% | 43% | 86% | 67% | 100% | 100% | 100% | 82% | 96% |
| Top 10 | 100% | 100% | 100% | 95% | 57% | 100% | 87% | 100% | 100% | 100% | 91% | 98% |
| Average Rank | 2.5 | 1.7 | 1.2 | 1.6 | 10.7 | 2.3 | 4.7 | 1.3 | 4 | 2 | 3.7 | 1.6 |
| Experiments | 10 | 10 | 22 | 22 | 7 | 7 | 15 | 15 | 1 | 1 | 55 | 55 |